Among @ patients treated with BMS who were randomized to continued thienopyridine vs placebo , rates of stent thrombosis were @ % vs @ % ( n = @ vs @ ; hazard ratio -LSB- HR -RSB- , @ ; @ % CI , @-@ @ ; P = @ ) , rates of MACCE were @ % vs @ % ( n = @ vs @ ; HR , @ ; @ % CI , @-@ @ ; P = @ ) , and rates of moderate/severe bleeding were @ % vs @ % ( n = @ vs @ ; P = @ ) , respectively .